| Takeda Pharma AG - TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze |
| 68178 | | 01 | | TAKHZYRO 300 mg | | Injektionslösung in einer Fertigspritze | | B06AC05 | | Lanadelumab | | 05.11.2020 | | |
|
| Composition |
| lanadelumabum 300 mg, dinatrii phosphas dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 6.91 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Lanadelumabum | 300mg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Lanadelumabum | 300 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate Dihydrate | | Histidine | | Sodium Chloride | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 9412.34 | 9964.85 | B | SL | No |
|
